Cite this article
Volume | Year
European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Primary mediastinal choriocarcinoma with brain metastasis in a female patient
I. Kuno1,*, Y. Matsumoto2, M. Kasai1, T. Fukuda1, Y. Hashiguchi1, T. Ichimura1, T. Yasui1, T. Sumi1
1 Department of Obstetrics and Gynecology, Osaka City University, Graduate School of Medicine, Osaka, Japan
1 Department of Obstetrics and Gynecology, Kishiwada City Hospital, Osaka, Japan
Eur. J. Gynaecol. Oncol. 2016, 37(2), 265–266; https://doi.org/10.12892/ejgo2833.2016
Published: 10 April 2016
Nongestational choriocarcinoma is very rare and carries a poor prognosis in female patients. In this report, the authors present a case of nongestational choriocarcinoma with brain metastasis in a female. A 58-year-old female with intermittent back pain was referred to a private hospital. On examination, a mediastinal tumor and a pancreatic tumor were detected. Endoscopic ultrasound-guided fine needle aspiration biopsy of the tumor was performed for histological evaluation. Pathological diagnosis was difficult because only a small amount of tissue was collected. Head MRI showed multiple metastatic tumors in the brain. The patient was diagnosed with primary mediastinal choriocarcinoma with brain metastasis. She was treated with one course of an etoposide, methotrexate, dactinomycin, cyclophosphamide, and vincristine regimen, but her general condition gradually deteriorated, and she died on day 41. Nongestational choriocarcinoma is drug resistant, whereas gestational choriocarcinoma has better chemotherapeutic sensitivity.